Browse By Topic Infectious Diseases
Two COVID-19 vaccines have received emergency use authorization (EUA) in the U.S. But open questions remain, including the durability of immunity and how to predict rare, severe adverse reactions.
Now more than ever, the fate of pathogens in the air must be studied extensively from a multidisciplinary approach to handle current airborne diseases more efficiently and to prevent future spread.
Screening determines whether an asymptomatic person is likely to have or develop disease, while diagnostics identify the cause of a patient’s illness - a crucial difference in the context of COVID-19.